JP5395997B2 - 孟宗竹由来竹エキス含有竹塩及びその製造方法 - Google Patents
孟宗竹由来竹エキス含有竹塩及びその製造方法 Download PDFInfo
- Publication number
- JP5395997B2 JP5395997B2 JP2006238870A JP2006238870A JP5395997B2 JP 5395997 B2 JP5395997 B2 JP 5395997B2 JP 2006238870 A JP2006238870 A JP 2006238870A JP 2006238870 A JP2006238870 A JP 2006238870A JP 5395997 B2 JP5395997 B2 JP 5395997B2
- Authority
- JP
- Japan
- Prior art keywords
- bamboo
- salt
- extract
- bamboo extract
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims description 186
- 235000017491 Bambusa tulda Nutrition 0.000 title claims description 186
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims description 186
- 241001330002 Bambuseae Species 0.000 title claims description 185
- 239000011425 bamboo Substances 0.000 title claims description 185
- 239000000284 extract Substances 0.000 title claims description 120
- 150000003839 salts Chemical class 0.000 title claims description 76
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 235000002639 sodium chloride Nutrition 0.000 claims description 86
- 238000001035 drying Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 238000004090 dissolution Methods 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 235000010755 mineral Nutrition 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- 244000294411 Mirabilis expansa Species 0.000 claims description 7
- 235000015429 Mirabilis expansa Nutrition 0.000 claims description 7
- 235000011203 Origanum Nutrition 0.000 claims description 7
- 240000000783 Origanum majorana Species 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- 235000013536 miso Nutrition 0.000 claims description 7
- 239000013535 sea water Substances 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- -1 rock salt Yes Chemical class 0.000 claims description 4
- 240000000249 Morus alba Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000001603 reducing effect Effects 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 241000209128 Bambusa Species 0.000 claims 1
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229930191978 Gibberellin Natural products 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003448 gibberellin Substances 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 4
- 239000004062 cytokinin Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000000491 Tendinopathy Diseases 0.000 description 2
- 206010043255 Tendonitis Diseases 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940047122 interleukins Drugs 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000005976 liver dysfunction Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 201000004415 tendinitis Diseases 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241000123826 Lutjanus campechanus Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047627 Vitamin deficiencies Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
Description
以下に、孟宗竹由来竹エキス含有竹塩を鼻孔又は舌下に使用した実施例を示す。
文京区在住の59歳女性は、時折飛蚊症で悩まされていたが、鼻孔の粘膜上に綿棒で孟宗竹由来竹エキス含有竹塩を2度添加することにより、黒い斑点状のものが目の前に現れなくなった。千葉県流山市在住の65歳の男性は、顔が時折痙攣し、肩が常に重苦しかったが、鼻孔の粘膜上に綿棒で孟宗竹由来竹エキス含有竹塩を少量だけ数度添加することにより、鼻の中に結石状のものが出て、顔の痙攣が取れ、肩が楽になった。埼玉県川越市在住の60歳の男性は、煙を吸い込むと喉が痛くなる症状があったが、舌下に耳掻き一杯分の孟宗竹由来竹エキス含有竹塩を投入することにより、たんが出て急速に改善された。この他鼻炎や扁桃痛等の改善例が多数有る。
2、3 竹ヘラ
4、5 柄杓
6 乾燥用容器
7 掻き混ぜ用ヘラ
21、31 貫通穴
22、32、71 柄
Claims (8)
- 95℃以上100℃以下に加熱した水で抽出した孟宗竹由来竹エキスに対して、20〜30重量%の塩を溶解させて、前記竹エキスの水分を70%〜90%蒸発させ、乾燥させて成る孟宗竹由来竹エキス含有竹塩であって、前記竹エキスにはマジョラムエキス及び赤紫蘇エキスが添加され、前記塩が塩化ナトリウム、海水から製造された塩、又は岩塩などの自然塩のいずれかであり、前記孟宗竹由来竹エキス含有竹塩は、前記塩が核として使用されることにより粉体化されて成り、前記孟宗竹由来竹エキス含有竹塩は、前記孟宗竹由来竹エキスに含まれるカルシウム、カリウム、マグネシウム、亜鉛及びリン等のミネラル類、並びにビタミンB6等のビタミン類が濃縮された状態で、含有されていることを特徴とする孟宗竹由来竹エキス含有竹塩。
- 請求項1に記載の孟宗竹由来竹エキス含有竹塩の製造方法であって、粉砕若しくは微細に割った孟宗竹を水に浸漬し、前記水を95℃以上100℃以下に加熱し、3時間〜5時間程度煮詰めて孟宗竹由来竹エキスを抽出する工程と、抽出された前記竹エキスにマジョラムエキス及び赤紫蘇エキスを添加したものを第1容器に入れた後に、20〜30重量%の塩を溶解させる工程と、前記溶解工程にて得られた溶解液を攪拌しながら95℃以上100℃以下に保温して水分を70%〜90%蒸発させて濃縮し、前記竹エキスを含有した濃縮塩を得る工程と、前記濃縮塩を第2容器に入れて、乾燥させると共に、15分乃至30分おきに掻き混ぜることにより、前記孟宗竹由来竹エキス含有竹塩を得る工程とを具備し、前記塩が塩化ナトリウム、海水から製造された塩、又は岩塩などの自然塩のいずれかであり、前記孟宗竹由来竹エキス含有竹塩は、前記塩が核として使用されることにより粉体化されて成り、前記孟宗竹由来竹エキス含有竹塩は、前記孟宗竹由来竹エキスに含まれるカルシウム、カリウム、マグネシウム、亜鉛及びリン等のミネラル類、並びにビタミンB6等のビタミン類が濃縮された状態で、含有されていることを特徴とする孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記乾燥を天日に当てることによって行う請求項2に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記乾燥を乾燥室に入れて減圧することによって行う請求項2又は3に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記乾燥を真空乾燥で行う請求項2又は3に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記掻き混ぜる作業を天地を掻き混ぜることによって行う請求項2乃至5のいずれか1項に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記第1容器がロート状の形状になっている請求項2乃至6のいずれか1項に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
- 前記第2容器が皿型の形状になっている請求項2乃至7のいずれか1項に記載の孟宗竹由来竹エキス含有竹塩の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006238870A JP5395997B2 (ja) | 2006-09-04 | 2006-09-04 | 孟宗竹由来竹エキス含有竹塩及びその製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006238870A JP5395997B2 (ja) | 2006-09-04 | 2006-09-04 | 孟宗竹由来竹エキス含有竹塩及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008056648A JP2008056648A (ja) | 2008-03-13 |
JP5395997B2 true JP5395997B2 (ja) | 2014-01-22 |
Family
ID=39239821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006238870A Active JP5395997B2 (ja) | 2006-09-04 | 2006-09-04 | 孟宗竹由来竹エキス含有竹塩及びその製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5395997B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101452338B1 (ko) | 2013-05-29 | 2014-10-22 | 담양군 | 대나무 부산물을 이용한 소금의 제조 방법 및 그 방법에 의하여 얻어진 소금 |
CN111972665A (zh) * | 2019-05-21 | 2020-11-24 | 江苏省制盐工业研究所有限公司 | 一种含复合氨基酸和多糖的竹笋提取液及其制备方法和由其制备的竹盐 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890004712A (ko) * | 1987-09-10 | 1989-05-09 | 김윤세 | 핵비소 함유 죽염 및 그 제조방법 |
JPH0676290B2 (ja) * | 1989-01-06 | 1994-09-28 | 日本油脂株式会社 | 抗菌剤 |
JPH02292206A (ja) * | 1989-05-02 | 1990-12-03 | Nippon Oil & Fats Co Ltd | 静菌剤の製造法 |
KR940000064B1 (ko) * | 1990-12-28 | 1994-01-05 | 주식회사 럭키 | 죽염을 함유하는 치약 조성물 |
JPH07298852A (ja) * | 1994-05-06 | 1995-11-14 | Tokai Denshi Netsuren Kk | 竹エキス入り食品添加剤ならびにその製造方法 |
JP4135207B2 (ja) * | 1998-03-19 | 2008-08-20 | 日油株式会社 | 抗菌剤 |
JP4317937B2 (ja) * | 1998-09-02 | 2009-08-19 | 関 正敏 | カルシウム含有活性液の製造方法及びその製造方法で製造されるカルシウム含有活性液 |
JP3554684B2 (ja) * | 1999-10-01 | 2004-08-18 | 英元 日下 | 竹エキスの抽出方法、竹エキスとハーブ等を配合した調味液及びその製造方法 |
JP2003171293A (ja) * | 2001-12-10 | 2003-06-17 | Shiro Yamashita | 竹エキス海塩混合液の製造方法 |
WO2005079824A1 (ja) * | 2004-02-25 | 2005-09-01 | Hidemoto Kusaka | 竹エキスを主成分とした飲料及び医薬 |
JP2006094795A (ja) * | 2004-09-30 | 2006-04-13 | Hidemoto Kusaka | 竹エキスを使用した食品およびその加工方法 |
-
2006
- 2006-09-04 JP JP2006238870A patent/JP5395997B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008056648A (ja) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101539508B1 (ko) | 기능성 소금 및 그 제조방법 | |
CN102599262A (zh) | 一种林蛙油及其加工方法以及林蛙油饮料 | |
CN102550779A (zh) | 一种果脯及其生产方法 | |
CN102389003A (zh) | 一种红参茶饮料及其制备方法 | |
KR101602717B1 (ko) | 뽕잎 소금의 제조방법 | |
JP5395997B2 (ja) | 孟宗竹由来竹エキス含有竹塩及びその製造方法 | |
CN101341997A (zh) | 平贝雪梨饮料及其制备工艺 | |
CN106396504A (zh) | 一种多功能室内装修材料及其制备方法 | |
JP5045969B2 (ja) | 免疫力が強化された組成物の製造方法及びそれによる組成物 | |
CN106727024A (zh) | 一种油茶漱口液及其制备方法 | |
CN1883309A (zh) | 一种鹿骨颗粒剂 | |
CN105617019A (zh) | 含有铁皮石斛超微粉的泡腾颗粒组合物 | |
JP2019193617A (ja) | ケイ素ベースの食品添加物の製造方法 | |
KR101405492B1 (ko) | 삼채분말이 코팅된 소금 조성물 및 그 제조방법 | |
CN102599517A (zh) | 一种生姜加工副产物生产超微姜粉的方法 | |
CN106085251A (zh) | 一种从草鱼鱼皮中提取明胶的方法 | |
CN102217696B (zh) | 莪术保健茶及其加工方法 | |
CN106343579A (zh) | 一种鱼鳔胶原蛋白小肽螯合钙的制备方法 | |
KR20050080501A (ko) | 고혈압, 비만, 당뇨병환자를 위한 건강보조식품의 제조방법 | |
CN104473270A (zh) | 一种核桃浆的制备方法及其制备的核桃浆 | |
CN107893001A (zh) | 一种含藤茶提取液的天然手工皂 | |
CN108450861A (zh) | 一种与数种中草药配制的蜂蜜 | |
CN105617108A (zh) | 一种治疗肝炎的丸剂及制备方法 | |
CN106333362A (zh) | 一种活血散淤的阿胶粉及其制备方法 | |
CN106819249A (zh) | 一种覆盆子滋补肝肾果味茶膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090827 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120515 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120705 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130326 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130801 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130801 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130822 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131015 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131021 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5395997 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |